Streetbeat News

Stock Prices

ARGX

Truist Securities analyst Joon Lee has reiterated a Buy rating on argenx (NASDAQ:ARGX) and maintained a price target of $550.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 4:37 pm

BP

USO

Oil prices have risen for a third consecutive day, with Brent crude surpassing $80 a barrel and WTI at $75.06, driven by tensions in the Middle East. The United States Oil Fund (USO) has seen a 0.9% increase and an 8.9% gain over the past week. Rising tensions are due to Yemeni Houthi rebel attacks in the Red Sea, prompting BP to suspend shipments and other shippers to reroute, leading to higher shipping and insurance costs. These factors may contribute to a short-term spike in oil prices, but the impact is expected to be brief unless the situation persists.

Portfolio Pulse from Neil Dennis

December 20, 2023 | 4:36 pm

DESP

Despegar.com's stock (DESP) is trading higher following an endorsement from B. Riley Securities, which maintained a Buy rating and increased the price target from $12 to $15.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 4:35 pm

RRR

Truist Securities analyst Barry Jonas has maintained a Hold rating on Red Rock Resorts (NASDAQ:RRR) and increased the price target from $46 to $55.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 4:33 pm

HUBS

Over the past 5 years, HubSpot (NYSE:HUBS) has delivered an average annual return of 35.54%, outperforming the market by 21.48%. A $100 investment in HUBS 5 years ago would be worth $495.86 today. HubSpot's market capitalization currently stands at $28.56 billion.

Portfolio Pulse from Benzinga Insights

December 20, 2023 | 4:30 pm

CNC

Over the past 20 years, Centene (NYSE:CNC) has delivered an average annual return of 16.32%, outperforming the market by 8.78% annually. A $100 investment in CNC stock 20 years ago would be worth $2,055.34 today. Centene's market cap stands at $39.81 billion.

Portfolio Pulse from Benzinga Insights

December 20, 2023 | 4:30 pm

EXAS

Exact Sciences Corporation (NASDAQ:EXAS) stock is trading higher, with an over 8% gain in the past month. Guggenheim analyst Subbu Nambi initiated coverage with a Buy rating and a $90 price target, while Wolfe Research analyst Doug Schenkel also initiated coverage with an Outperform rating. Exact Sciences presented new data at the 2023 San Antonio Breast Cancer Symposium. The stock is experiencing above-average trading volume, with shares up by 4.2% at $72.33.

Portfolio Pulse from Erica Kollmann

December 20, 2023 | 4:27 pm

SCS

Steelcase (SCS) shares rose following the report of Q3 2024 adjusted EPS that exceeded expectations, along with the issuance of Q4 guidance.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 4:26 pm

ICU

SeaStar Medical Holding Corp has submitted a hearing request to a panel to appeal a delisting determination, according to a recent SEC filing.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 4:26 pm

SEMR

Traders are paying attention to SEMrush Holdings (SEMR) following a mention in the Zacks Blockchain Innovators newsletter, which is known for picking stocks.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 4:26 pm